1. China Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Allmed Medical Products Co., Ltd. Class A

Allmed Medical Products Co., Ltd. Class A

SSZSE:002950
8.19
CNY
+0.13
(+1.61%)
0.36EPS
26.51P/E
5.63BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
2.69
2.5
2.68
3.05
3.61
3.83
6.06
4.63
6.65
4.24
5.32
5.93
6.21
Basic EPS, GAAP
0.35
0.25
0.43
0.42
0.41
0.53
1.83
0.68
0.64
0.17
0.59
0.4
0.34
Free Cash Flow per Basic Share
0.36
0.19
0.54
-0.37
-0.51
0.07
1.89
0.13
1.19
0.21
0.89
0.74
- -
Dividend per Share
0.13
0.16
0.51
0.33
0.06
0.17
0.42
0.91
0.26
0.1
0.07
0.08
0.23
Book Value per Share
1.29
1.75
1.79
1.94
2.34
3.24
4.6
4.35
4.9
5.03
5.43
5.68
5.83
Tangible Book Value per Share
1.16
1.55
1.6
1.6
2.01
2.99
4.25
3.94
4.4
4.56
4.99
5.17
5.31
Basic Weighted Avg Shares
561
633
582
561
561
615
633
632
633
649
625
619
617
Sales/Revenue/Turnover
1,509
1,585
1,558
1,711
2,028
2,352
3,834
2,926
4,211
2,757
3,326
3,672
3,831
Operating Margin (%)
16.95
17.22
19.07
16.37
15.57
17.66
32.49
15.66
20.84
11.8
14.77
16.2
15.97
Depreciation Expense
66
74
77
84
111
121
142
147
193
227
229
243
- -
Net Income, GAAP
198
157
248
234
228
326
1,158
431
407
110
369
249
207
Effective Tax Rate (%)
16.97
18.89
15.49
17.35
18.12
17.75
13.31
14.55
16.55
38.35
18.84
16.79
12.57
Profit Margin (%)
13.15
9.9
15.93
13.66
11.23
13.85
30.19
14.74
9.66
4
11.08
6.78
5.4
Working Capital
-39
277
216
194
336
1,043
1,370
605
332
454
820
1,076
844
LT Debt
- -
- -
- -
154
228
187
101
128
111
151
90
173
548
Total Equity
742
994
1,018
1,099
1,322
2,059
2,923
2,752
3,131
3,211
3,448
3,615
3,725
Return on Invested Capital (%)
- -
9.23
16.02
14.21
10.81
12.61
33.86
10.43
10.75
2.53
8.96
6.2
5
Return on Capital (%)
- -
12.03
17.93
15.94
12.53
14.22
34.65
10.92
10.82
3.31
9.4
5.99
4.52
Return on Common Equity (%)
- -
18.4
24.95
22.31
18.98
19.37
46.65
15.23
13.9
3.51
11.13
7.08
5.74

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
634
602
674
LT Borrowings
115
364
489
LT Finance Leases
59
58
58
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
633
633
633
Market Capitalization
6,915
7,625
5,630

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
2,405
2,342
2,267
Cash, Cash Equivalents & STI
972
770
472
Accounts Receivable, Net
518
464
459
Inventories
720
820
918
Total Current Liabilities
1,329
1,269
1,423
Payables & Accruals
- -
- -
- -
ST Debt
634
602
674
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
15.11%
4.54%
4.84%
Free Cash Flow
366.71%
181.12%
-17.64%
Net Income, GAAP
40.82%
12.04%
-32.49%
Sales/Revenue/Turnover
12.24%
3.35%
10.38%
Total Cash Common Dividend
40.63%
-5.79%
18.68%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
746
835
868
876
3,326
2025
759
918
- -
1,075
3,672
2026
896
942
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.15
0.15
0.13
0.17
0.59
2025
0.14
0.18
- -
-0.16
0.4
2026
0.18
0.14
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.04
0.01
0.01
0.07
2025
0.01
0.07
- -
0.01
0.08
2026
0.01
0.15
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Jin Hai Cui
Full Time Employees
6,158
Sector
Health technology
Industry
Medical specialties
Address
No. 18, Qixing Avenue Zhijiang HB China 443200
IPO Date
Mar 11, 2019
Website
allmed-china.com
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Allmed Medical Products Co., Ltd. specializes in the comprehensive development, production, and distribution of an extensive range of medical dressings and healthcare materials. The company’s offerings are categorized into several key areas, including a wide array of wound care and nursing products. These encompass general wound management items such as elastic and adhesive bandages, specialized oil emulsion and xeroform gauze dressings, various woven and non-woven gauze swabs, absorbent fluffy bandages and sponges, abdominal pads, non-stick pads, and petrolatum gauze. Allmed also provides advanced wound care solutions. Beyond wound care, the company delivers essential operating room and surgical products, which feature X-ray non-woven and gauze swabs, OR towels, laparotomy and neuro sponges, X-ray detectable gauze and non-woven balls, as well as a variety of surgical gowns and drapes. Additionally, Allmed is a significant provider of infection control materials and customized procedure kits. For patient care, its product portfolio includes disposable nursing pads and medical drapes. Allmed Medical Products Co., Ltd. operates both domestically and internationally, exporting its comprehensive product line to over 70 countries and regions across six continents, establishing a notable global presence, with key markets including the United States, Canada, Germany, and Japan. The company was originally established in Hong Kong in 1997 and subsequently listed on the Shenzhen Stock Exchange in March 2019 under the ticker 002950.SZ. Headquartered in Shenzhen, People's Republic of China, Allmed is recognized for its integrated, large-scale, and intelligent manufacturing capabilities across medical dressings, infection control products, and medical non-woven items. Recent activities include participation in global medical conferences, as well as share repurchase programs and a strategic acquisition in the Chinese medical products sector.